Angio Suites Market By Offering (Systems (Single Plane System & Biplane System) and Services); By Procedure Type (Interventional Radiology & Oncology, Interventional Cardiology, Hybrid Surgery, Neuro Intervention, Electrophysiology, and Others); By End Users (Hospitals, Clinics, and Others); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
In the global angio suites market, the major drivers contributing to the market growth are government funding along with the development of new innovative medical devices. Due to increasing incidence of life-threatening diseases, diagnostics procedures are increasing all over the world. The direct and indirect costs of diagnosis as well as imaging are observed to have increased over the period of time. In order to develop cost-effective and efficient medical devices, various governments in developed countries are actively funding research & development (R&D) activities, which is contributing towards the growth of global angio suites market.
In 2017 – 2018, the State Government of New South Wales (NSW) in Australia sanctioned medical devices fund of about US$ 8 million as the government wanted to encourage and support investments in the development and commercialization of medical devices and other related technologies. Private companies are also investing into R&D, which is anticipated to further boost the growth of global angio suites market. In August 2021, Biosensors established a global R&D center that was meant to provide round-the-clock R&D services. Many innovation centers have been set up in Shanghai, Singapore, California, and Europe in line with the company’s global expansion strategies within the global angio suites market.
High costs associated with the installation of angio suites is restraining the growth of global angio suites market. In countries where medical infrastructure is not developed, especially those in the Middle East & Africa, the lack of skilled professionals and standard usage guidelines is significantly impacting the market growth. However, various government are spending heavily on developing healthcare sector in their countries, which is anticipated to address the concerns, thus favoring the growth of global angio suites market. For instance, in August 2019, due to high costs, U.S. Food and Drug Administration (FDA) decided to replace pressure wires and adenosine with image-based fractional flow reserve (FFR). FDA cleared three new angiography imaging-based FFR assessments for use in catheterization laboratory.
In March 2021, according to the data presented at the virtual International Stroke Conference, it was concluded that the direct transfer to angiography suite workflow could increase the number of patients who received endovascular treatment. Compared with a direct to CT suite workflow, it could also reduce door-to-groin and onset-to-reperfusion times. The medical treatments where angio suite plays an important role are becoming more advanced and more efficient, which is estimated to propel the growth of global angio suite market over the forecast period.
For diagnosis and treatment of China-originated coronavirus, many countries are planning to align coronary CT angiography protocols with current acquisition guidance so that accurate diagnosis and optimal image quality can be ensured. The use of telemedicine is also increasing for COVID-19 diagnosis. Hence, the market for COVID-19 treatment methods and accessories has huge opportunities for the growth of global angio suites market. In October 2020, a journal of the American Stroke Association, published a report highlighting that the lung scans for stroke patients could provide detection of COVID-19 at an earlier stage. Report elaborated this theory, stating that during acute ischemic stroke (AIS), evaluation of the lung apices using computed tomography (CT) angiography of the head and neck could provide the first objective opportunity to screen for coronavirus.
The rise in implementation of artificial intelligence (AI) and analytics in diagnostic imaging and growing adoption of teleradiology showcase significant growth opportunities for global angio suites market over the period of next eight years. In the field of teleradiology, AI is one of the most promising breakthroughs. Across all the major imaging modalities, the adoption of AI is higher in CT and magnetic resonance imaging (MRI) systems. Based on applications, AI is heavily used in neuroradiology. In July 2020, Lunit expanded collaboration with GE Healthcare to advance AI adoption. Two companies are working together to develop AI algorithms from Lunit INSIGHT Chest radiograph (CXR) that are available through GE Healthcare’s Thoracic Care Suite. This would help the whole medical sector to alleviate clinical strain among radiologists and improve patient outcomes.
In terms of revenue, angio suites market was valued at US$ 1412.90 Mn in 2020 growing at a CAGR of 5.9% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Angio Suites Market Revenue & Forecast, (US $ Million), 2015 – 2029
Offering Outlook:
In the context of offering, the global angio suites market has been primarily segmented into systems and services. The systems segment has been further classified into single plane system and biplane system. The systems segment accounted for the largest market share in 2020. The market for single plane system is helpful in wide range of procedures that include interventional neurology, interventional cardiology, interventional radiology & oncology, and peripheral studies. Single plane imaging is often preferred in procedures useful for the treatment of patients without renal impairment.In September 2019, FDA cleared artis icono family of angiography systems developed by Siemens Healthineers. This product family includes biplane and floor single-plane angiography systems that were designed to improve interventional lab utilization and interdisciplinary usage.
Bi-plane imaging is often preferred for the treatment of patients with renal impairment. Biplane system has been designed to support a variety of procedures such as electrophysiology, pediatrics, neuro interventions and body imaging procedures. This system can provide the image clarity that is required while helping to keep the dose as low as possible. In July 2021, Norwalk Hospital opened new biplane angiography suite. In September 2020, a Bi-Plane Catheterization (Cath) Lab was also constructed at the San Fernando General Hospital (SFGH).
The service segment is expected to achieve tremendous growth in global angio suites market during the forecast period (2021 – 2029).
Procedure Type Outlook:
On the basis of procedure types, the global angio suites market has been segmented into interventional radiology & oncology, interventional cardiology, hybrid surgery, neuro intervention, electrophysiology, and others. Interventional cardiology accounted for the largest market share in angio suites market in 2020 and during the forecast period (2021 – 2029), this segment is expected to retain its market position and become the fastest growing market segment. Medical systems offer dose management and imaging technologies that are helpful in diagnosis. Today advanced imaging such as multi-modality fusion can provide additional views of the vascular anatomy which can aid clinicians during interventional procedures. Through enhanced visualization during interventional procedures, clinicians and doctors can obtain improved imaging chain with new hardware technology as well as software technology that offer fast and assured visualization. Display systems can provide additional views of the vascular anatomy, which would aid clinicians during interventional procedures. Advanced tools useful for interventional cardiology help doctors to navigate with confidence and accuracy with noise reduction technology. They provide clean, sharp, and defined images during stent placement or ablation procedures. Other advantages that can keep the market for interventional cardiology go strong for this decade are accessibility of the artery in most patients, enhancement of comfort due to patients being able to sit up, and the easy control of bleeding even in anticoagulated patients.
In April 2021, FDA sanctioned the 510(k) clearance for the application software called Philips SmartCT, which has been developed by Philips Healthcare. This software is a component of Philips Azurion Image Guided Therapy System and provides interventionalists with CT. It also aids the follow-up for interventional cardiology and radiology cath lab procedures.
End Users Outlook:
Based on end users, the global angio suites market has been segmented into hospitals, clinics, and others. Clinics segment accounted for the largest market share in global angio suites market in 2020. Clinics, which provide concentrated therapies and diagnosis, are increasingly investing towards implementation of advanced technologies including angio suits, which has contributed towards the segment’s growth in the global market. In January 2021, FDA cleared Ultromics Echocardiography AI-based solution called EchoGo Pro that could be useful for the automated identification of coronary artery disease. During the forecast period, the hospital end user segment is anticipated to register highest growth rate.
Region Outlook:
North America accounted for a significant share in the angio suites market in 2020. However, during the forecast period, Asia Pacific region is expected to witness highest growth rate due to huge patient population with heart diseases in Asian countries and rising geriatric population. According to World Health Organization (WHO) compiled in 2015, Asia's elderly population count was projected to reach nearly 923 million by 2050. Government’s support for improvement of the healthcare sector in countries like India and Japan are likely to contribute to the market growth.
Competitive Landscape Outlook:
The report provides both, qualitative as well as quantitative research of global angio suites market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the angio suites market are 3D Systems Inc., Canon Medical Systems Corporation, GE Healthcare, Guerbet, Phillips Healthcare, Shimadzu Corporation, Siemens Healthcare, and Zeiss Group amongst others.
Global Angio Suites Market:
By Offering
- Systems
- Single Plane System
- Biplane System
- Services
By Procedure Type
- Interventional Radiology and Oncology
- Interventional Cardiology
- Hybrid Surgery
- Neuro Intervention
- Electrophysiology
- Others
By End Users
- Hospitals
- Clinics
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. 1Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Angio Suites Market
6. Market
Synopsis: Angio Suites Market
7. Angio
Suites Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Angio Suites Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Angio Suites Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Angio Suites Market
8. Global
Angio Suites Market Analysis and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Angio Suites Market Revenue (US$ Mn)
8.2. Global
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Systems
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Single Plane System, Biplane
System)
8.2.1.1. Single
Plane System
8.2.1.2. Biplane
System
8.2.2. Services
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 - 2020
8.2.2.3. Market
Forecast, 2021 - 2029
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global
Angio Suites Market Analysis and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
9.2.1. Interventional
Radiology and Oncology
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2020
9.2.1.3. Market
Forecast, 2021 - 2029
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Interventional
Cardiology
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2020
9.2.2.3. Market
Forecast, 2021 - 2029
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Hybrid
Surgery
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2020
9.2.3.3. Market
Forecast, 2021 - 2029
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Neuro
Intervention
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2020
9.2.4.3. Market
Forecast, 2021 - 2029
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Electrophysiology
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 - 2020
9.2.5.3. Market
Forecast, 2021 - 2029
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 - 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 - 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.2.6. Others
9.2.6.1. Definition
9.2.6.2. Market
Estimation and Penetration, 2015 - 2020
9.2.6.3. Market
Forecast, 2021 - 2029
9.2.6.4. Compound
Annual Growth Rate (CAGR)
9.2.6.5. Regional
Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2015 - 2020
9.2.6.5.1.2. Market
Forecast, 2021 - 2029
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2020
9.2.6.5.2.2. Market
Forecast, 2021 - 2029
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2020
9.2.6.5.3.2. Market
Forecast, 2021 - 2029
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2020
9.2.6.5.4.2. Market
Forecast, 2021 - 2029
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2015 - 2020
9.2.6.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Procedure Type
10. Global
Angio Suites Market Analysis and Forecasts, 2021 – 2029
10.1. Overview
10.2. Global
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
10.2.1. Hospitals
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2020
10.2.1.3. Market
Forecast, 2021 - 2029
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Clinics
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 - 2020
10.2.2.3. Market
Forecast, 2021 - 2029
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Others
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 - 2020
10.2.3.3. Market
Forecast, 2021 - 2029
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By End
Users
11. North
America Angio Suites Market Analysis and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North
America Angio Suites Market Revenue (US$ Mn)
11.2. North
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
11.2.1. Systems
11.2.1.1. Single
Plane System
11.2.1.2. Biplane
System
11.2.2. Services
11.3. North
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
11.3.1. Interventional
Radiology and Oncology
11.3.2. Interventional
Cardiology
11.3.3. Hybrid
Surgery
11.3.4. Neuro
Intervention
11.3.5. Electrophysiology
11.3.6. Others
11.4. North
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. North
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.1.1.1. Systems
11.5.1.1.1.1. Single
Plane System
11.5.1.1.1.2. Biplane
System
11.5.1.1.2. Services
11.5.1.2. U.S
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
11.5.1.2.1. Interventional
Radiology and Oncology
11.5.1.2.2. Interventional
Cardiology
11.5.1.2.3. Hybrid
Surgery
11.5.1.2.4. Neuro
Intervention
11.5.1.2.5. Electrophysiology
11.5.1.2.6. Others
11.5.1.3. U.S
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.1.3.1. Hospitals
11.5.1.3.2. Clinics
11.5.1.3.3. Others
11.5.2. Canada
11.5.2.1. Canada
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.2.1.1. Systems
11.5.2.1.1.1. Single
Plane System
11.5.2.1.1.2. Biplane
System
11.5.2.1.2. Services
11.5.2.2. Canada
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
11.5.2.2.1. Interventional
Radiology and Oncology
11.5.2.2.2. Interventional
Cardiology
11.5.2.2.3. Hybrid
Surgery
11.5.2.2.4. Neuro
Intervention
11.5.2.2.5. Electrophysiology
11.5.2.2.6. Others
11.5.2.3. Canada
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.2.3.1. Hospitals
11.5.2.3.2. Clinics
11.5.2.3.3. Others
11.5.3. Mexico
11.5.3.1. Mexico
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
11.5.3.1.1. Systems
11.5.3.1.1.1. Single
Plane System
11.5.3.1.1.2. Biplane
System
11.5.3.1.2. Services
11.5.3.2. Mexico
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
11.5.3.2.1. Interventional
Radiology and Oncology
11.5.3.2.2. Interventional
Cardiology
11.5.3.2.3. Hybrid
Surgery
11.5.3.2.4. Neuro
Intervention
11.5.3.2.5. Electrophysiology
11.5.3.2.6. Others
11.5.3.3. Mexico
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.3.3.1. Hospitals
11.5.3.3.2. Clinics
11.5.3.3.3. Others
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Angio Suites Market Revenue (US$ Mn) and Forecasts, By
Offering
11.5.4.1.1. Systems
11.5.4.1.1.1. Single
Plane System
11.5.4.1.1.2. Biplane
System
11.5.4.1.2. Services
11.5.4.2. Rest
of North America Angio Suites Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
11.5.4.2.1. Interventional
Radiology and Oncology
11.5.4.2.2. Interventional
Cardiology
11.5.4.2.3. Hybrid
Surgery
11.5.4.2.4. Neuro
Intervention
11.5.4.2.5. Electrophysiology
11.5.4.2.6. Others
11.5.4.3. Rest
of North America Angio Suites Market Revenue (US$ Mn) and Forecasts, By End
Users
11.5.4.3.1. Hospitals
11.5.4.3.2. Clinics
11.5.4.3.3. Others
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Offering
11.6.3. By
Procedure Type
11.6.4. By End
Users
12. Europe
Angio Suites Market Analysis and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Europe
Angio Suites Market Revenue (US$ Mn)
12.2. Europe
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Systems
12.2.1.1. Single
Plane System
12.2.1.2. Biplane
System
12.2.2. Services
12.3. Europe
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.3.1. Interventional
Radiology and Oncology
12.3.2. Interventional
Cardiology
12.3.3. Hybrid
Surgery
12.3.4. Neuro
Intervention
12.3.5. Electrophysiology
12.3.6. Others
12.4. Europe
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Europe
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.1.1.1. Systems
12.5.1.1.1.1. Single
Plane System
12.5.1.1.1.2. Biplane
System
12.5.1.1.2. Services
12.5.1.2. France
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.1.2.1. Interventional
Radiology and Oncology
12.5.1.2.2. Interventional
Cardiology
12.5.1.2.3. Hybrid
Surgery
12.5.1.2.4. Neuro
Intervention
12.5.1.2.5. Electrophysiology
12.5.1.2.6. Others
12.5.1.3. France
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1.3.1. Hospitals
12.5.1.3.2. Clinics
12.5.1.3.3. Others
12.5.2. The UK
12.5.2.1. The
UK Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.2.1.1. Systems
12.5.2.1.1.1. Single
Plane System
12.5.2.1.1.2. Biplane
System
12.5.2.1.2. Services
12.5.2.2. The
UK Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.2.2.1. Interventional
Radiology and Oncology
12.5.2.2.2. Interventional
Cardiology
12.5.2.2.3. Hybrid
Surgery
12.5.2.2.4. Neuro
Intervention
12.5.2.2.5. Electrophysiology
12.5.2.2.6. Others
12.5.2.3. The
UK Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.2.3.1. Hospitals
12.5.2.3.2. Clinics
12.5.2.3.3. Others
12.5.3. Spain
12.5.3.1. Spain
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.3.1.1. Systems
12.5.3.1.1.1. Single
Plane System
12.5.3.1.1.2. Biplane
System
12.5.3.1.2. Services
12.5.3.2. Spain
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.3.2.1. Interventional
Radiology and Oncology
12.5.3.2.2. Interventional
Cardiology
12.5.3.2.3. Hybrid
Surgery
12.5.3.2.4. Neuro
Intervention
12.5.3.2.5. Electrophysiology
12.5.3.2.6. Others
12.5.3.3. Spain
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.3.3.1. Hospitals
12.5.3.3.2. Clinics
12.5.3.3.3. Others
12.5.4. Germany
12.5.4.1. Germany
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.4.1.1. Systems
12.5.4.1.1.1. Single
Plane System
12.5.4.1.1.2. Biplane
System
12.5.4.1.2. Services
12.5.4.2. Germany
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.4.2.1. Interventional
Radiology and Oncology
12.5.4.2.2. Interventional
Cardiology
12.5.4.2.3. Hybrid
Surgery
12.5.4.2.4. Neuro
Intervention
12.5.4.2.5. Electrophysiology
12.5.4.2.6. Others
12.5.4.3. Germany
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.4.3.1. Hospitals
12.5.4.3.2. Clinics
12.5.4.3.3. Others
12.5.5. Italy
12.5.5.1. Italy
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.5.1.1. Systems
12.5.5.1.1.1. Single
Plane System
12.5.5.1.1.2. Biplane
System
12.5.5.1.2. Services
12.5.5.2. Italy
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.5.2.1. Interventional
Radiology and Oncology
12.5.5.2.2. Interventional
Cardiology
12.5.5.2.3. Hybrid
Surgery
12.5.5.2.4. Neuro
Intervention
12.5.5.2.5. Electrophysiology
12.5.5.2.6. Others
12.5.5.3. Italy
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.5.3.1. Hospitals
12.5.5.3.2. Clinics
12.5.5.3.3. Others
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.6.1.1. Systems
12.5.6.1.1.1. Single
Plane System
12.5.6.1.1.2. Biplane
System
12.5.6.1.2. Services
12.5.6.2. Nordic
Countries Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.6.2.1. Interventional
Radiology and Oncology
12.5.6.2.2. Interventional
Cardiology
12.5.6.2.3. Hybrid
Surgery
12.5.6.2.4. Neuro
Intervention
12.5.6.2.5. Electrophysiology
12.5.6.2.6. Others
12.5.6.3. Nordic
Countries Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.6.3.1. Hospitals
12.5.6.3.2. Clinics
12.5.6.3.3. Others
12.5.6.4. Nordic
Countries Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.7.1.1. Systems
12.5.7.1.1.1. Single
Plane System
12.5.7.1.1.2. Biplane
System
12.5.7.1.2. Services
12.5.7.2. Benelux
Union Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.7.2.1. Interventional
Radiology and Oncology
12.5.7.2.2. Interventional
Cardiology
12.5.7.2.3. Hybrid
Surgery
12.5.7.2.4. Neuro
Intervention
12.5.7.2.5. Electrophysiology
12.5.7.2.6. Others
12.5.7.3. Benelux
Union Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.3.1. Hospitals
12.5.7.3.2. Clinics
12.5.7.3.3. Others
12.5.7.4. Benelux
Union Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The
Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
12.5.8.1.1. Systems
12.5.8.1.1.1. Single
Plane System
12.5.8.1.1.2. Biplane
System
12.5.8.1.2. Services
12.5.8.2. Rest
of Europe Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
12.5.8.2.1. Interventional
Radiology and Oncology
12.5.8.2.2. Interventional
Cardiology
12.5.8.2.3. Hybrid
Surgery
12.5.8.2.4. Neuro
Intervention
12.5.8.2.5. Electrophysiology
12.5.8.2.6. Others
12.5.8.3. Rest
of Europe Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.3.1. Hospitals
12.5.8.3.2. Clinics
12.5.8.3.3. Others
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Offering
12.6.3. By
Procedure Type
12.6.4. By End
Users
13. Asia
Pacific Angio Suites Market Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia
Pacific Angio Suites Market Revenue (US$ Mn)
13.2. Asia
Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Systems
13.2.1.1. Single
Plane System
13.2.1.2. Biplane
System
13.2.2. Services
13.3. Asia
Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.3.1. Interventional
Radiology and Oncology
13.3.2. Interventional
Cardiology
13.3.3. Hybrid
Surgery
13.3.4. Neuro
Intervention
13.3.5. Electrophysiology
13.3.6. Others
13.4. Asia
Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Asia
Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.1.1.1. Systems
13.5.1.1.1.1. Single
Plane System
13.5.1.1.1.2. Biplane
System
13.5.1.1.2. Services
13.5.1.2. China
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.1.2.1. Interventional
Radiology and Oncology
13.5.1.2.2. Interventional
Cardiology
13.5.1.2.3. Hybrid
Surgery
13.5.1.2.4. Neuro
Intervention
13.5.1.2.5. Electrophysiology
13.5.1.2.6. Others
13.5.1.3. China
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1.3.1. Hospitals
13.5.1.3.2. Clinics
13.5.1.3.3. Others
13.5.2. Japan
13.5.2.1. Japan
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.2.1.1. Systems
13.5.2.1.1.1. Single
Plane System
13.5.2.1.1.2. Biplane
System
13.5.2.1.2. Services
13.5.2.2. Japan
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.2.2.1. Interventional
Radiology and Oncology
13.5.2.2.2. Interventional
Cardiology
13.5.2.2.3. Hybrid
Surgery
13.5.2.2.4. Neuro
Intervention
13.5.2.2.5. Electrophysiology
13.5.2.2.6. Others
13.5.2.3. Japan
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.2.3.1. Hospitals
13.5.2.3.2. Clinics
13.5.2.3.3. Others
13.5.3. India
13.5.3.1. India
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.3.1.1. Systems
13.5.3.1.1.1. Single
Plane System
13.5.3.1.1.2. Biplane
System
13.5.3.1.2. Services
13.5.3.2. India
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.3.2.1. Interventional
Radiology and Oncology
13.5.3.2.2. Interventional
Cardiology
13.5.3.2.3. Hybrid
Surgery
13.5.3.2.4. Neuro
Intervention
13.5.3.2.5. Electrophysiology
13.5.3.2.6. Others
13.5.3.3. India
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.3.3.1. Hospitals
13.5.3.3.2. Clinics
13.5.3.3.3. Others
13.5.4. New
Zealand
13.5.4.1. New
Zealand Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.4.1.1. Systems
13.5.4.1.1.1. Single
Plane System
13.5.4.1.1.2. Biplane
System
13.5.4.1.2. Services
13.5.4.2. New
Zealand Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.4.2.1. Interventional
Radiology and Oncology
13.5.4.2.2. Interventional
Cardiology
13.5.4.2.3. Hybrid
Surgery
13.5.4.2.4. Neuro
Intervention
13.5.4.2.5. Electrophysiology
13.5.4.2.6. Others
13.5.4.3. New
Zealand Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.4.3.1. Hospitals
13.5.4.3.2. Clinics
13.5.4.3.3. Others
13.5.5. Australia
13.5.5.1. Australia
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.5.1.1. Systems
13.5.5.1.1.1. Single
Plane System
13.5.5.1.1.2. Biplane
System
13.5.5.1.2. Services
13.5.5.2. Australia
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.5.2.1. Interventional
Radiology and Oncology
13.5.5.2.2. Interventional
Cardiology
13.5.5.2.3. Hybrid
Surgery
13.5.5.2.4. Neuro
Intervention
13.5.5.2.5. Electrophysiology
13.5.5.2.6. Others
13.5.5.3. Australia
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.5.3.1. Hospitals
13.5.5.3.2. Clinics
13.5.5.3.3. Others
13.5.6. South
Korea
13.5.6.1. South
Korea Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.6.1.1. Systems
13.5.6.1.1.1. Single
Plane System
13.5.6.1.1.2. Biplane
System
13.5.6.1.2. Services
13.5.6.2. South
Korea Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.6.2.1. Interventional
Radiology and Oncology
13.5.6.2.2. Interventional
Cardiology
13.5.6.2.3. Hybrid
Surgery
13.5.6.2.4. Neuro
Intervention
13.5.6.2.5. Electrophysiology
13.5.6.2.6. Others
13.5.6.3. South
Korea Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.6.3.1. Hospitals
13.5.6.3.2. Clinics
13.5.6.3.3. Others
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.7.1.1. Systems
13.5.7.1.1.1. Single
Plane System
13.5.7.1.1.2. Biplane
System
13.5.7.1.2. Services
13.5.7.2. Southeast
Asia Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.5.7.2.1. Interventional
Radiology and Oncology
13.5.7.2.2. Interventional
Cardiology
13.5.7.2.3. Hybrid
Surgery
13.5.7.2.4. Neuro
Intervention
13.5.7.2.5. Electrophysiology
13.5.7.2.6. Others
13.5.7.3. Southeast
Asia Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.3.1. Hospitals
13.5.7.3.2. Clinics
13.5.7.3.3. Others
13.5.7.4. Southeast
Asia Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest
of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
13.5.8.1.1. Systems
13.5.8.1.1.1. Single
Plane System
13.5.8.1.1.2. Biplane
System
13.5.8.1.2. Services
13.5.8.2. Rest
of Asia Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
13.5.8.2.1. Interventional
Radiology and Oncology
13.5.8.2.2. Interventional
Cardiology
13.5.8.2.3. Hybrid
Surgery
13.5.8.2.4. Neuro
Intervention
13.5.8.2.5. Electrophysiology
13.5.8.2.6. Others
13.5.8.3. Rest
of Asia Pacific Angio Suites Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.8.3.1. Hospitals
13.5.8.3.2. Clinics
13.5.8.3.3. Others
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Offering
13.6.3. By
Procedure Type
13.6.4. By End
Users
14. Middle
East and Africa Angio Suites Market Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle
East and Africa Angio Suites Market Revenue (US$ Mn)
14.2. Middle
East and Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Systems
14.2.1.1. Single
Plane System
14.2.1.2. Biplane
System
14.2.2. Services
14.3. Middle
East and Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
14.3.1. Interventional
Radiology and Oncology
14.3.2. Interventional
Cardiology
14.3.3. Hybrid
Surgery
14.3.4. Neuro
Intervention
14.3.5. Electrophysiology
14.3.6. Others
14.4. Middle
East and Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By End
Users
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Others
14.5. Middle
East and Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.1.1.1. Systems
14.5.1.1.1.1. Single
Plane System
14.5.1.1.1.2. Biplane
System
14.5.1.1.2. Services
14.5.1.2. Saudi
Arabia Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
14.5.1.2.1. Interventional
Radiology and Oncology
14.5.1.2.2. Interventional
Cardiology
14.5.1.2.3. Hybrid
Surgery
14.5.1.2.4. Neuro
Intervention
14.5.1.2.5. Electrophysiology
14.5.1.2.6. Others
14.5.1.3. Saudi
Arabia Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.3.1. Hospitals
14.5.1.3.2. Clinics
14.5.1.3.3. Others
14.5.2. UAE
14.5.2.1. UAE
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.2.1.1. Systems
14.5.2.1.1.1. Single
Plane System
14.5.2.1.1.2. Biplane
System
14.5.2.1.2. Services
14.5.2.2. UAE
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
14.5.2.2.1. Interventional
Radiology and Oncology
14.5.2.2.2. Interventional
Cardiology
14.5.2.2.3. Hybrid
Surgery
14.5.2.2.4. Neuro
Intervention
14.5.2.2.5. Electrophysiology
14.5.2.2.6. Others
14.5.2.3. UAE
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.2.3.1. Hospitals
14.5.2.3.2. Clinics
14.5.2.3.3. Others
14.5.3. Egypt
14.5.3.1. Egypt
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.3.1.1. Systems
14.5.3.1.1.1. Single
Plane System
14.5.3.1.1.2. Biplane
System
14.5.3.1.2. Services
14.5.3.2. Egypt
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
14.5.3.2.1. Interventional
Radiology and Oncology
14.5.3.2.2. Interventional
Cardiology
14.5.3.2.3. Hybrid
Surgery
14.5.3.2.4. Neuro
Intervention
14.5.3.2.5. Electrophysiology
14.5.3.2.6. Others
14.5.3.3. Egypt
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.3.3.1. Hospitals
14.5.3.3.2. Clinics
14.5.3.3.3. Others
14.5.4. Kuwait
14.5.4.1. Kuwait
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.4.1.1. Systems
14.5.4.1.1.1. Single
Plane System
14.5.4.1.1.2. Biplane
System
14.5.4.1.2. Services
14.5.4.2. Kuwait
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
14.5.4.2.1. Interventional
Radiology and Oncology
14.5.4.2.2. Interventional
Cardiology
14.5.4.2.3. Hybrid
Surgery
14.5.4.2.4. Neuro
Intervention
14.5.4.2.5. Electrophysiology
14.5.4.2.6. Others
14.5.4.3. Kuwait
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.4.3.1. Hospitals
14.5.4.3.2. Clinics
14.5.4.3.3. Others
14.5.5. South
Africa
14.5.5.1. South
Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
14.5.5.1.1. Systems
14.5.5.1.1.1. Single
Plane System
14.5.5.1.1.2. Biplane
System
14.5.5.1.2. Services
14.5.5.2. South
Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
14.5.5.2.1. Interventional
Radiology and Oncology
14.5.5.2.2. Interventional
Cardiology
14.5.5.2.3. Hybrid
Surgery
14.5.5.2.4. Neuro
Intervention
14.5.5.2.5. Electrophysiology
14.5.5.2.6. Others
14.5.5.3. South
Africa Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.3.1. Hospitals
14.5.5.3.2. Clinics
14.5.5.3.3. Others
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Angio Suites Market Revenue (US$ Mn) and Forecasts,
By Offering
14.5.6.1.1. Systems
14.5.6.1.1.1. Single
Plane System
14.5.6.1.1.2. Biplane
System
14.5.6.1.2. Services
14.5.6.2. Rest
of Middle East & Africa Angio Suites Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
14.5.6.2.1. Interventional
Radiology and Oncology
14.5.6.2.2. Interventional
Cardiology
14.5.6.2.3. Hybrid
Surgery
14.5.6.2.4. Neuro
Intervention
14.5.6.2.5. Electrophysiology
14.5.6.2.6. Others
14.5.6.3. Rest
of Middle East & Africa Angio Suites Market Revenue (US$ Mn) and Forecasts,
By End Users
14.5.6.3.1. Hospitals
14.5.6.3.2. Clinics
14.5.6.3.3. Others
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Offering
14.6.3. By
Procedure Type
14.6.4. By End
Users
15. Latin
America Angio Suites Market Analysis and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin
America Angio Suites Market Revenue (US$ Mn)
15.2. Latin
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
15.2.1. Systems
15.2.1.1. Single
Plane System
15.2.1.2. Biplane
System
15.2.2. Services
15.3. Latin
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
15.3.1. Interventional
Radiology and Oncology
15.3.2. Interventional
Cardiology
15.3.3. Hybrid
Surgery
15.3.4. Neuro
Intervention
15.3.5. Electrophysiology
15.3.6. Others
15.4. Latin
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
15.4.1. Hospitals
15.4.2. Clinics
15.4.3. Others
15.5. Latin
America Angio Suites Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.1.1.1. Systems
15.5.1.1.1.1. Single
Plane System
15.5.1.1.1.2. Biplane
System
15.5.1.1.2. Services
15.5.1.2. Brazil
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
15.5.1.2.1. Interventional
Radiology and Oncology
15.5.1.2.2. Interventional
Cardiology
15.5.1.2.3. Hybrid
Surgery
15.5.1.2.4. Neuro
Intervention
15.5.1.2.5. Electrophysiology
15.5.1.2.6. Others
15.5.1.3. Brazil
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1.3.1. Hospitals
15.5.1.3.2. Clinics
15.5.1.3.3. Others
15.5.2. Argentina
15.5.2.1. Argentina
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Offering
15.5.2.1.1. Systems
15.5.2.1.1.1. Single
Plane System
15.5.2.1.1.2. Biplane
System
15.5.2.1.2. Services
15.5.2.2. Argentina
Angio Suites Market Revenue (US$ Mn) and Forecasts, By Procedure Type
15.5.2.2.1. Interventional
Radiology and Oncology
15.5.2.2.2. Interventional
Cardiology
15.5.2.2.3. Hybrid
Surgery
15.5.2.2.4. Neuro
Intervention
15.5.2.2.5. Electrophysiology
15.5.2.2.6. Others
15.5.2.3. Argentina
Angio Suites Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.2.3.1. Hospitals
15.5.2.3.2. Clinics
15.5.2.3.3. Others
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Angio Suites Market Revenue (US$ Mn) and Forecasts, By
Offering
15.5.3.1.1. Systems
15.5.3.1.1.1. Single
Plane System
15.5.3.1.1.2. Biplane
System
15.5.3.1.2. Services
15.5.3.2. Rest
of Latin America Angio Suites Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
15.5.3.2.1. Interventional
Radiology and Oncology
15.5.3.2.2. Interventional
Cardiology
15.5.3.2.3. Hybrid
Surgery
15.5.3.2.4. Neuro
Intervention
15.5.3.2.5. Electrophysiology
15.5.3.2.6. Others
15.5.3.3. Rest
of Latin America Angio Suites Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.3.3.1. Hospitals
15.5.3.3.2. Clinics
15.5.3.3.3. Others
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By Offering
15.6.3. By
Procedure Type
15.6.4. By End
Users
16. Competitive
Benchmarking
16.1. Market
Share Analysis, 2020
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player
Profiles
17.1. 3D
Systems, Inc.
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Canon
Medical Systems Corporation
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. GE
Healthcare
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business Strategies
17.4. Guerbet
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Phillips Healthcare
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Shimadzu Corporation
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Siemens Healthcare
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. Zeiss Group
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Other Market Participants
18. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
